These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6286777)

  • 1. Low binding of Bolton-Hunter-labelled cholecystokinin-33 to carboxyl-terminal CCK-antibodies.
    Jansen JB; Lamers CB
    J Immunol Methods; 1982 Jun; 51(2):223-30. PubMed ID: 6286777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of antisera to cholecystokinin by use of different cholecystokinin labels.
    Jansen JB; Lamers CB
    J Immunol Methods; 1984 Jun; 71(1):1-8. PubMed ID: 6539353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of cholecystokinin: comparison of different tracers.
    Cantor P; Rehfeld JF
    J Immunol Methods; 1985 Sep; 82(1):47-55. PubMed ID: 2411820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of 125I-Bolton-Hunter labelled cholecystokinin binding in human brain.
    Cross AJ; Slater P; Skan W
    Neuropeptides; 1988; 11(2):73-6. PubMed ID: 3368039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I-(Thr34, Nle37)- CCK31-39 a non oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides.
    Fourmy D; Pradayrol L; Vaysse N; Susini C; Ribet A
    J Immunoassay; 1984; 5(1-2):99-120. PubMed ID: 6201510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas.
    Le Meuth V; Philouze-Rome V; Le Huerou-Luron I; Formal M; Vaysse N; Gespach C; Guilloteau P; Fourmy D
    Endocrinology; 1993 Sep; 133(3):1182-91. PubMed ID: 8365360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using [125I]Bolton Hunter-cholecystokinin octapeptide.
    Lin CW; Miller T
    J Pharmacol Exp Ther; 1985 Mar; 232(3):775-80. PubMed ID: 2983069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of biologically active radioiodinated cholecystokinin for radioreceptor assay and radioimmunoassay.
    Sankaran H; Deveney CW; Goldfine ID; Williams JA
    J Biol Chem; 1979 Oct; 254(19):9349-51. PubMed ID: 226515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and biochemical characterization of cholecystokinin/gastrin receptors in developing rat pancreas. Age-related expression of distinct receptor glycoforms.
    Hadjiivanova C; Dufresne M; Poirot S; Sozzani P; Vaysse N; Moroder L; Fourmy D
    Eur J Biochem; 1992 Feb; 204(1):273-9. PubMed ID: 1740139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of cholecystokinin-pancreozymin.
    Harvey RF; Dowsett L; Hartog M; Read AE
    Gut; 1974 Sep; 15(9):690-9. PubMed ID: 4435583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cholecystokinin receptors on bovine gallbladder membranes.
    Steigerwalt RW; Goldfine ID; Williams JA
    Am J Physiol; 1984 Dec; 247(6 Pt 1):G709-14. PubMed ID: 6095678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of receptors for cholecystokinin and related peptides in mouse cerebral cortex.
    Saito A; Goldfine ID; Williams JA
    J Neurochem; 1981 Aug; 37(2):483-90. PubMed ID: 6267205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
    Graham WC; Hill DR; Woodruff GN; Sambrook MA; Crossman AR
    Neurosci Lett; 1991 Sep; 131(1):129-34. PubMed ID: 1791971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK 8 and CCK 4 cholecystokinin receptor binding site.
    Clark CR; Daum P; Hughes J
    J Neurochem; 1986 Apr; 46(4):1094-101. PubMed ID: 3005503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay of cholecystokinin in human tissue and plasma.
    Jansen JB; Lamers CB
    Clin Chim Acta; 1983 Jul; 131(3):305-16. PubMed ID: 6883724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and heterogeneity of immunoreactive cholecystokinin (CCK) in the mucosa of the porcine gastrointestinal tract.
    Bacarese-Hamilton AJ; Adrian TE; Bloom SR
    Regul Pept; 1984 Nov; 9(4):289-98. PubMed ID: 6522644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide.
    Hoosein NM; Kiener PA; Curry RC; Brattain MG
    Exp Cell Res; 1990 Jan; 186(1):15-21. PubMed ID: 2298233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.